Welcome to our dedicated page for JIN MED INTL LTD. news (Ticker: ZJYL), a resource for investors and traders seeking the latest updates and insights on JIN MED INTL LTD. stock.
Jin Medical International Ltd. (Nasdaq: ZJYL) is a Cayman Islands holding company with Chinese operating entities that manufacture wheelchairs, rehabilitation medical equipment and living aids products. This news page aggregates announcements, press releases and updates related to Jin Medical’s operations, product lines, collaborations and capital markets activity.
Company news often covers developments in its rehabilitation equipment and assistive technology portfolio, including manual and electric wheelchairs, nano-thermal bath equipment, micro-hyperbaric oxygen chambers and lifestyle beauty and health devices. Updates have highlighted expansion of manufacturing capacity, such as the construction and launch of production at the intelligent manufacturing facility in Chuzhou, Anhui Province, as well as the operation of existing plants in Changzhou and Taizhou in Jiangsu Province.
Jin Medical’s releases also describe strategic projects and partnerships, including orders for micro-hyperbaric oxygen chambers, cooperation on lifestyle beauty equipment, participation in elderly care initiatives like the "Lao Le Hui" Assisted Bathing Project, and potential acquisitions in the medical equipment sharing field. Capital markets and regulatory items, such as Nasdaq listing notifications and financial result announcements, are reported through SEC filings and accompanying press communications.
Investors, analysts and observers can use this news feed to follow how Jin Medical’s rehabilitation and health-related products are being deployed, how its manufacturing footprint evolves, and how management communicates about listing compliance, governance changes and financial performance. Regularly reviewing these updates provides context on the company’s activities within the surgical and medical instrument manufacturing sector and its role in assistive technologies and health-focused equipment.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Jin Medical International Ltd. (NASDAQ: ZJYL) announced the partial exercise of the over-allotment option by Prime Number Capital, LLC, resulting in the purchase of 47,355 ordinary shares at $8.00 per share. This adds $378,840 to the IPO's gross proceeds, which now total $8,378,840 before offering expenses. The IPO, facilitated by Prime Number Capital as the sole bookrunner, was declared effective by the SEC on March 27, 2023. The company operates in the wheelchair and living aids sector, with established manufacturing plants and relationships with over 40 distributors.
Along with its IPO announcement, the company highlighted its manufacturing capabilities and innovative product designs, holding over 100 patents and continually enhancing product offerings for market competitiveness.
Jin Medical International Ltd. (NASDAQ: ZJYL) has successfully closed its initial public offering (IPO) on March 30, 2023, raising $8 million from the sale of 1,000,000 ordinary shares at $8.00 per share. The underwriters have an option to purchase an additional 150,000 shares for over-allotments. Proceeds from the offering will be allocated to various initiatives including R&D, marketing, and production capacity enhancements, as well as potential acquisitions. Shares began trading on the Nasdaq Capital Market on March 28, 2023. The company operates in the wheelchair and living aids sector, with established market connections in China and Japan.
FAQ
What is the current stock price of JIN MED INTL LTD. (ZJYL)?
What is the market cap of JIN MED INTL LTD. (ZJYL)?
